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Background: This study investigated factors related to ethnicity and educational level, their correlation with tumor
stage at the time of diagnosis, and their influence on treatment outcomes in patients with prostate cancer.
Methods: In this retrospective observational study, we analyzed the medical records of 1,349 male patients treated
for prostatic adenocarcinoma. We collected information about sociodemographic variables, including educational
level and self-reported skin color. We also classified the disease according whether it was to more likely to present
with metastasis and measured the tumor response to treatment.
Results: Less-educated (<8 years of education) individuals were 4.8 times more likely to develop metastasis than
those with more education (>11 years of education; p < 0.001). Similarly, patients with a self-reported black skin
color had a 300% increased risk of metastasis at diagnosis (p = 0.001). Distant metastasis was independently
correlated with worse outcomes, such that individuals with distant metastasis were 10 times more likely to die than
were those without distant metastasis.
Conclusions: Patients with self-reported black skin color and <8 years of education were more likely to display
advanced disease at the time of diagnosis compared with their counterparts. Only the presence of metastasis was
independently associated with mortality or progressive disease.
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Prostate adenocarcinoma is the sixth most prevalent
cancer in the world and the most common cancer among
men in Europe, North America, and parts of Africa. After
non-melanoma skin cancer, prostate adenocarcinoma is
the second most often diagnosed cancer and the third
leading cause of cancer-related deaths in the United States
(US) [1]. In addition, prostate adenocarcinoma is the
second most prevalent cancer in Brazil, with an estimated
60,180 new cases in 2012. According to the National
Cancer Institute of Brazil, the increase in incidence rates
may be explained by increased life expectancy, improvement* Correspondence: araujojr@cb.ufrn.br
1Department of Morphology, Federal University of Rio Grande do Norte,
Natal 59072-970, Rio Grande do Norte, Brazil
Full list of author information is available at the end of the article
© 2013 de Souza et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the orin and development of diagnostic methods, and improved
quality of information systems in Brazil [2].
There are differences in prostate adenocarcinoma rates
across ethnic groups. In the US, African-Americans have
the highest disease rate compared with other ethnicities.
Caucasians have an approximately 60% lower rate of pros-
tate adenocarcinoma diagnosis than do African-Americans,
and the prevalence is even lower among those with a
Latin American or Asian origin [3]. Differential genetic
susceptibility and socioeconomic and environmental
factors likely contribute to the observed differences in
incidence rates among ethnicities [4-7]. For example,
obesity is one of the most studied factors in cancer.
Obesity has been associated with increased exposure to
carcinogens in the diet [8], increased cardiovascular risk
[9], higher prevalence of high-grade prostate canceral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Descriptive data
Variable n % Mean SD
Age (years) 71.25 9.10
≤50 23 1.7
51 − 60 151 11.2
61 − 70 401 29.7
71 − 80 562 41.7
81 − 90 205 15.2
>90 7 0.5
Educational level (years)Ξ - -
<8 504 66.9
>11 249 33.1







Hormone therapy 512 40.1
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[10-13]. Thus, several factors are involved in prostate
adenocarcinoma epidemiology, and the identification of
useful prognostic factors for this neoplasm is extremely
important for understanding the disease.
The most important clinical factors currently available
are the prostate-specific antigen (PSA) level and histological
differentiation degree in tumor biopsy fragments; these
two markers are expressed as the Gleason score [14,15].
Although the Gleason score is valuable, its sole use does
not define patient prognosis for prostate cancer [16].
Consequently, additional comprehensive studies of prog-
nostic factors for prostatic adenocarcinoma are necessary
to find the population that is most in need of attention
and early diagnosis.
This study aimed to identify ethnic and educational levels
as additional factors related to prostate adenocarcinoma,
determine their correlation with tumor stage at the time
of diagnosis, and elucidate their influence on patient
outcomes.
Methods
The institutional committees (No. 030/0030/2006) of the
Liga Norteriograndense Contra o Cancer, Brazil, approved
this research.
This transversal study included the retrospective
analysis of mortality or progressive disease state in 1,349
male patients with biopsy-confirmed prostate adenocar-
cinoma (International Classification of Diseases, 10th
edition, code C61). Patients were treated between 1997
and 2005 at Luis Antonio Hospital, a Brazilian Health
System cancer referral center in Natal, Brazil. Natal is the
capital of Rio Grande do Norte State in the northeastern
part of the country and has a population of >1 million
inhabitants. Trained researchers collected data, which
included hospital and medical records, between August
2007 and May 2008.
From all cases, researchers gathered medical record data
related to the variables of interest: patient age at cancer
diagnosis, race/ethnicity, residential address at diagnosis,
tumor stage and grade, deaths, age, and educational level
(<8 years = incomplete elementary school; >11 years = high
school completion). Race/ethnicity was classified according
to the mutually exclusive self-report for skin color
(black: yes or no). After diagnosis, we defined the disease
as either aggressive or nonaggressive. Regional or distant
tumors based on imaging study results were classified
as aggressive, while tumors confined to the prostate
(localized) were nonaggressive. The endpoint was mortality
or progressive disease at the end of the first stage of
treatment (first consultation after hospital treatment,
with 2 weeks to 1 month).
A chi-squared test determined the distribution differ-
ences of educational status and skin color. Multivariatelogistic regression models examined the influence of
socioeconomic factors on the presence of metastasis at
diagnosis and patient outcome after the first stage of
treatment. Regression analyses were conducted in two steps:
Model 1 assessed the correlation of each socioeconomic
variable with the presence or absence of metastasis at
diagnosis, and Model 2 adjusted education status and skin
color for the presence of metastasis to determine the
impact of these variables on mortality. The analyses showed
no colinearity. All statistics were performed using SPSS
software (ver. 13.0 for Windows; SPSS Inc., Chicago, IL,
USA) with a significance level of p < 0.05.
Results
Table 1 shows the descriptive data of the study participants.
Univariate analysis showed a significant correlation
between the presence of aggressive metastasis and
educational levels (p < 0.001) and self-reported skin
color (p = 0.006), suggesting that these variables are risk
factors for distant metastasis at the time of diagnosis.
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and demonstrated independent correlations: the chance of
developing an aggressive metastasis was increased 4.8-fold
in patients with <8 years of education compared with
those who had received >11 years of education (p < 0.001).
Moreover, patients with a self-reported black skin color
showed a 300% increase in aggressive metastasis compared
with patients of other skin colors (p = 0.001).
Although self-reported skin color was not associated
with mortality or progressive disease, low educational
levels (p = 0.002) and the presence of metastasis (p < 0.001)
were positively associated with the endpoint. The results
from the multivariate regression analyses demonstrated
that only the presence of aggressive metastasis was
independently correlated with a negative outcome, such
that patients with distant metastasis were 10 times more
likely to die (Table 2).
Discussion
The inaccurate prediction of treatment outcomes for
patients with prostate cancer is a public health problem
because different treatment options are associated with
different morbidity rates. For example, erectile dysfunction
affects 80% of patients who have undergone radical
prostatectomy [16]. The identification of additional prog-
nostic factors will thus help physicians select the most
appropriate treatment for each case.
Our results that a lower educational level was related
to an increased likelihood of having a metastasis at the
time of diagnosis may be due to decreased healthcare
use among less-educated patients. Individuals who do
not seek treatment or do not have access to healthcare
may receive a delayed diagnosis and be less likely to
adhere to treatment regimens. In contrast, well-educated
individuals are more likely to undergo timely screening
(PSA testing) and urological monitoring. A study conducted
in Sao Paulo State in Brazil found that 44% of 992 men
with a low socioeconomic status had never received aTable 2 Multivariate regression analyses
Metastasis
Yes (%) p OR (95% CI)
Educational level (years) <0.001 4.778 (2.821–8.
<8 104 (25.2)
>11 24 (10.4)




Yes 272 (100.0) -
No 0 (0.0)
OR odds ratio, CI confidence interval.preventive examination for prostate adenocarcinoma; this
pattern was most prevalent among men aged <70 years,
those with a black or brown skin color, and those
with <9 years of education [17]. Another study in Sao
Paulo showed high mortality rates among men living in
poor areas, which may be related to a lack of access to
preventive cancer screening [18]. In addition, a significant
association between low educational level and prostate
cancer incidence was demonstrated in a cohort from a
US study. Although these subjects were followed for an
average of 8.2 years, a strong association with cancer
dissemination was not found [19].
Individuals with African descent have been associated
with higher prostate cancer incidence rates and worse
prognoses compared with individuals of Caucasian eth-
nicity. A United Kingdom study found that the incidence
of prostate cancer was 166/100,000 among black men
(black Caribbean, black Africans, and black unclassified),
but only 56.4/100,000 among white men [20]. This
difference in incidence rates has also been documented
in the US, where African-American men show a higher
incidence of prostate cancer, have a 2-fold greater likelihood
of future disease development, and display twice the
mortality risk compared with Caucasian men [21,22].
Based upon previous findings and our current results,
African descent and a low educational level may have
interacting effects on prostate cancer treatment outcomes.
In several countries throughout the world, individuals of
African descent receive less education than do other ethnic
groups, such as Caucasians; however, studies have shown
that factors related to the lack of education alone cannot
explain the treatment outcomes associated with this group.
It is possible that genetic factors inherent to this popula-
tion, including the expression of genes related to androgen
activity, affect the presentation of prostate cancer. For
example, young men of African descent have higher
testosterone levels and exhibit changes in androgen
receptors. These factors may account for the higherMortality or progressive disease
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observed in this group, excluding the impact of socioeco-
nomic effects [23,24]. Therefore, while educational level
and genetic predispositions influence the development
and treatment of prostate cancer in individuals of African
ethnicity, the interaction between these variables may have
an even greater impact on disease outcomes.
We acknowledge that this study has limitations. First, this
was a retrospective study, and potential confounding effects
of complex variable relationships (i.e., PSA screening,
Gleason score, and number of prior physician visits) may
have limited our power of analysis. Unfortunately, these
variables could not be analyzed. Second, there may have
been variations or inaccuracies in patient self-reported
information, which may have biased our results. However,
we believe that the large sample size likely negated, or at
least minimized, possible bias.
Conclusions
This study demonstrated that men of African descent
and those with <8 years of education had a greater
chance of displaying advanced disease at the time of
diagnosis compared with patients of other skin colors
and higher educational level (>11 years). These findings
should guide improvements in the public health system
to change these patterns. Our results show that this
population deserves special attention to ensure early
diagnosis and treatment as well as improved health
outcomes. Further research should be conducted to
better understand these variables, other related factors, and
the relationships among genetic and sociodemographic
influences to improve prognostic classification in the
Brazilian population.
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